Prescription-only medicines. Product information on this site is intended for healthcare professionals in Pakistan.
Enquire Now →
Home›Medicines
Our portfolio

Specialist medicines across four therapeutic areas

Seven brands for hospital and specialist care in Pakistan. Choose a therapeutic area or a product to see its scientific and prescribing information.

Anti-InfectivesCritical care · hospital infection
Oncology & Bone HealthBone metastases · prostate cancer
UrologyBenign prostatic hyperplasia
GastroenterologyFunctional dyspepsia
Merovion® pack
Anti-Infectives

Merovion®

Meropenem USP
500 mg · 1 g vial
View product information →
Tigradox® pack
Anti-Infectives

Tigradox®

Tigecycline
50 mg vial
View product information →
Zolegen® pack
Oncology & Bone Health

Zolegen®

Zoledronic Acid
5 mg/100 mL · 4 mg/5 mL
View product information →
Pregolix® pack
Oncology & Bone Health

Pregolix®

Relugolix
120 mg tablets · 20s
View product information →
Tamstone-D® pack
Urology

Tamstone-D®

Tamsulosin HCl + Dutasteride
0.4 mg + 0.5 mg · 20 capsules
View product information →
Tamstone® pack
Urology

Tamstone®

Tamsulosin HCl
0.4 mg · 20 capsules
View product information →
Acosky® pack
Gastroenterology

Acosky®

Acotiamide HCl Hydrate
100 mg tablets · 20s
View product information →
Product pipeline

In development

Pipeline products are not marketed by Salventis Pharma. They are listed separately from the current portfolio, and their regulatory status is being confirmed against the current DRAP record.

Regulatory status to be confirmed

nab-Paclitaxel

Oncology

Regulatory status to be confirmed

Iohexol

Radiology · contrast media

Regulatory status to be confirmed

Gadobutrol

Radiology · contrast media

For healthcare professionals. All Salventis products are prescription-only medicines, to be sold on the prescription of a registered medical practitioner. Information on this site summarises the approved prescribing information and supplied product literature; it is not a substitute for the full prescribing information, which is available on request from Salventis Pharma. To report a suspected adverse reaction, contact info@salventispharma.com.